ApconiX Ion Channels archive
ApconiX Joins the MDC’s Virtual R&D platform ApconiX has joined the Medicines Discovery Catapult’s Virtual R&D platform. This is a unique national network of consultants, private sector CROs, expert labs and public sector centres of excellence, providing medicines discovery expertise, services and virtual programme management. ApconiX specialises in ion [...]
ApconiX Welcomes Sushma Pabbineedi. ApconiX is delighted to welcome Sushma Pabbineedi for a placement during May. Sushma will be working alongside Dr Michael Morton and Dr Karen Jones in the ion channel laboratory. Sushma studied Biomedical Sciences and gained a bachelor’s degree from Manchester Metropolitan University. She took a [...]
Identification of Selective Inhibitors of The Epithelial Sodium Channel ?. Victoria Miller, a PhD student from the Drug Discovery Centre at the University of Sussex recently spent a few months working in the ApconiX ion channel laboratory as a part of her research. Her PhD project titled “Identification of [...]
K2p3.1 protein is expressed as a transmural gradient across the rat left ventricular free wall Dr Michael Morton co-authored a paper recently published in the Journal of Cardiovascular Electrophysiology. The paper should serve as a reminder that ion channels which may not be the focus of regulatory guidance or [...]
SOT 58th Annual Meeting & ToxExpo - 2588: Talk by Dr Michael Morton of ApconiX At the Society of Toxicology 58th Annual Meeting and ToxExpo from March 10th to 14th at the Baltimore Convention Center, Dr Michael Morton of ApconiX will be giving a talk as part of the workshop [...]
SOT 58th Annual Meeting & ToxExpo - 2072: Poster Presentation by Richard Printemps of PhysioStim At the Society of Toxicology 58th Annual Meeting and ToxExpo from March 10th to 14th at the Baltimore Convention Center, poster presentation by Richard Printemps of PhysioStim on Tuesday March 12th 3:00pm - 4:30pm Poster [...]
ApconiX Opens a New Office in Sweden ApconiX is excited to announce the opening of our new office in Sweden. The subsidiary ApconiX AB will be located at AstraZeneca’s BioVentureHub in Gothenburg. ApconiX was formed by Dr Richard Knight, Dr Michael Morton and Professor Ruth Roberts in 2015 and [...]
ApconiX Welcomes Bethany Russell Bethany joins ApconiX as a placement student for part of September. A second-year student, Bethany is studying Biomedical Sciences at Sheffield University. Her degree is a four-year sandwich course, with a third-year placement in industry. Bethany was unsure if a career in a laboratory was [...]
ApconiX is supporting PhysioStim at SPS ApconiX and PhysioStim will be celebrating their first year of The European Centre of Excellence for preclinical cardiovascular electrophysiology at the Safety Pharmacology Society Annual Meeting in Washington this September. ApconiX will be supporting PhysioStim as they exhibit at the Marriott Wardman Park [...]
Dr Michael Morton will be speaking at EUROTOX this September in Belgium. On Tuesday September 4th at 16:30 in Hall 100 Mike will address ‘Cardiac safety: current state of the art’ chaired by Dr Mark Holbrook of VAST Pharma solutions and Ester Lovsin-Barle from Lonza. Mike will present ‘Ion channel profiling of stem cell-derived cardiomyocytes: [...]
